88 related articles for article (PubMed ID: 7903550)
1. Treatment of sympathetically maintained pain with terazosin.
Stevens DS; Robins VF; Price HM
Reg Anesth; 1993; 18(5):318-21. PubMed ID: 7903550
[TBL] [Abstract][Full Text] [Related]
2. Initial, long-term, and durable responses to terazosin, placebo, or other therapies for chronic prostatitis/chronic pelvic pain syndrome.
Cheah PY; Liong ML; Yuen KH; Teh CL; Khor T; Yang JR; Yap HW; Krieger JN
Urology; 2004 Nov; 64(5):881-6. PubMed ID: 15533470
[TBL] [Abstract][Full Text] [Related]
3. Terazosin: a new antihypertensive agent with favorable effects on lipids.
Luther RR
Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):313-9. PubMed ID: 2570758
[TBL] [Abstract][Full Text] [Related]
4. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.
Cheah PY; Liong ML; Yuen KH; Teh CL; Khor T; Yang JR; Yap HW; Krieger JN
J Urol; 2003 Feb; 169(2):592-6. PubMed ID: 12544314
[TBL] [Abstract][Full Text] [Related]
5. Terazosin: a new alpha 1-blocker for the treatment of hypertension: a review of randomized, controlled clinical trials of once-daily administration as monotherapy.
Luther RR; Glassman HN; Sperzel WD; Steinberg FJ; Horton JK; Jordan DC
J Hypertens Suppl; 1986 Dec; 4(5):S494-7. PubMed ID: 2883273
[TBL] [Abstract][Full Text] [Related]
6. Terazosin therapy for patients with female lower urinary tract symptoms: a randomized, double-blind, placebo controlled trial.
Low BY; Liong ML; Yuen KH; Chee C; Leong WS; Chong WL; Khan NA; Cheah PY; Liong KK
J Urol; 2008 Apr; 179(4):1461-9. PubMed ID: 18295277
[TBL] [Abstract][Full Text] [Related]
7. Clinical comparison of selective and non-selective alpha 1A-adrenoceptor antagonists for bladder outlet obstruction associated with benign prostatic hyperplasia: studies on tamsulosin and terazosin in Chinese patients. The Chinese Tamsulosin Study Group.
Na YJ; Guo YL; Gu FL
J Med; 1998; 29(5-6):289-304. PubMed ID: 10503165
[TBL] [Abstract][Full Text] [Related]
8. Terazosin: a new long-acting alpha 1-adrenergic antagonist for hypertension.
Frishman WH; Eisen G; Lapsker J
Med Clin North Am; 1988 Mar; 72(2):441-8. PubMed ID: 2894488
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of external RF hyperthermia combining with alpha 1-adrenergic receptor blocker for patients with prostatodynia and chronic non-bacterial prostatitis].
Wang J; Li J; Lu R; Wang JM
Zhonghua Nan Ke Xue; 2002; 8(1):48-50. PubMed ID: 12479049
[TBL] [Abstract][Full Text] [Related]
10. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
Itskovitz HD
Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
[TBL] [Abstract][Full Text] [Related]
11. Terazosin: a new alpha adrenoceptor blocking drug.
Achari R; Laddu A
J Clin Pharmacol; 1992 Jun; 32(6):520-3. PubMed ID: 1353083
[TBL] [Abstract][Full Text] [Related]
12. [Terazosine in the treatment of benign prostatic hypertrophy].
Caine M
J Urol (Paris); 1993; 99(6):311-3. PubMed ID: 7516376
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency lumbar sympatholysis. The evolution of a technique for managing sympathetically maintained pain.
Rocco AG
Reg Anesth; 1995; 20(1):3-12. PubMed ID: 7727325
[TBL] [Abstract][Full Text] [Related]
14. Long-term therapy with terazosin may improve glucose and lipid metabolism in hypertensives: a multicenter prospective study.
Shionoiri H; Gotoh E; Ito T; Hata T; Iwatsubo H; Takegawa K; Ogihara T; Mikami H; Ikegami H; Otsuka A
Am J Med Sci; 1994 Feb; 307 Suppl 1():S91-5. PubMed ID: 7908168
[TBL] [Abstract][Full Text] [Related]
15. Analgesic drugs for neuropathic and sympathetically maintained pain.
Lipman AG
Clin Geriatr Med; 1996 Aug; 12(3):501-15. PubMed ID: 8853942
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia.
Elhilali MM; Ramsey EW; Barkin J; Casey RW; Boake RC; Beland G; Fradet Y; Trachtenberg J; Orovan WL; Schick E; Klotz LH
Urology; 1996 Mar; 47(3):335-42. PubMed ID: 8633398
[TBL] [Abstract][Full Text] [Related]
17. The effect of terazosin on functional bladder outlet obstruction in women: a pilot study.
Kessler TM; Studer UE; Burkhard FC
J Urol; 2006 Oct; 176(4 Pt 1):1487-92. PubMed ID: 16952666
[TBL] [Abstract][Full Text] [Related]
18. Effects of terazosin in the treatment of benign prostatic hyperplasia. A pilot study.
Dunzendorfer U
Arzneimittelforschung; 1989 Oct; 39(10):1289-91. PubMed ID: 2482025
[TBL] [Abstract][Full Text] [Related]
19. Urodynamic effects of terazosin treatment for Japanese patients with symptomatic benign prostatic hyperplasia.
Tanaka Y; Masumori N; Itoh N; Sato Y; Takahashi A; Ogura H; Furuya S; Tsukamoto T
J Urol; 2002 Jun; 167(6):2492-5. PubMed ID: 11992065
[TBL] [Abstract][Full Text] [Related]
20. Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance.
Kyprianou N
J Urol; 2003 Apr; 169(4):1520-5. PubMed ID: 12629407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
